Omnicell Inc (OMCL)
Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell
$20.00
Buy
$45.96
$0.73 (+2.61%)
Prices updated at 14 May 2025, 09:00 EDT
| Prices minimum 15 mins delay
Prices in USD
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
---|---|---|
1,147m | 1,112m | |
497m | 471m | |
-35m | 337,000 | |
-3.04 | 0.03 | |
-20m | 13m | |
61m | 90m | |
Sales, General and administrative | 435m | 380m |
Interest expenses | - | - |
Provision for income taxes | 263,000 | 13m |
Operating expenses | 532m | 471m |
Income before taxes | -20m | 26m |
Net income available to common shareholders | -20m | 13m |
-0.45 | 0.27 | |
Net interest income | 15m | 25m |
Advertising and promotion | - | - |
Net investment income, net | - | - |
Realised capital gains (losses), net | - | - |
Total benefits, claims and expenses | - | - |
Earnings per share (diluted) | -0.45 | 0.27 |
Free cash flow per share | 3.6651 | 2.5794 |
Book value/share | 26.0751 | 26.5475 |
Debt equity ratio | 0.50765 | 0.158866 |
Balance sheet
Year | 2023 | 2024 |
---|---|---|
Current assets | 928m | 815m |
Current liabilities | 368m | 596m |
Total capital | 1,759m | 1,410m |
Total debt | 614m | 383m |
Total equity | 1,189m | 1,243m |
Total non current liabilities | - | - |
Loans | 570m | 166m |
Total assets | 2,227m | 2,121m |
Total liabilities | - | - |
Cash and cash equivalents | 468m | 369m |
Common stock | 46m | 46m |
Cash flow
Year | 2023 | 2024 |
---|---|---|
Cash at beginning of period | 353m | 501m |
Cash dividends paid | - | - |
126m | 135m | |
Investments (gains) losses | -55m | -53m |
501m | 399m | |
Net income | - | - |
181m | 188m | |
-55m | -53m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.